VINCRISTINE, IRINOTECAN AND TEMOZOLOMIDE TREATMENT FOR RECURRENT/PROGRESSIVE PEDIATRIC SOLID TUMORS

被引：0
|
作者：
Kebudi, R. [1 ]
Bay, S. Buyukkapu [1 ]
Cakir, F. B. [2 ]
Gorgun, O. [1 ]
Koc, B. [1 ]
Zulfikar, B. [1 ]
Agaoglu, F. Yaman [3 ]
Darendeliler, E. [3 ]
机构：
[1] Istanbul Univ, Cerrahpasa Med Fac, Pediat Hematol Oncol, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Med, Pediat Hematol Oncol, Istanbul, Turkey
[3] Istanbul Univ, Inst Oncol, Radiat Oncol, Istanbul, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-053
引用
收藏
页码：S158 / S159
页数：2
相关论文
共 50 条
  • [41] Reported Outcome of Recurrent Medulloblastoma Treated with Temozolomide and Irinotecan
    Sirachainan, N.
    Hansasuta, A.
    Pakakasama, S. Samart
    Auarathapan, U. Usanarat
    Dhanachai, M. Montana
    Hongeng, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S456 - S456
  • [42] Phase I study of irinotecan in pediatric patients with malignant solid tumors
    Mugishima, H
    Matsunaga, T
    Yagi, K
    Asami, K
    Mimaya, J
    Suita, S
    Kishimoto, T
    Sawada, T
    Tsuchida, Y
    Kaneko, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (02) : 94 - 100
  • [43] A pilot clinical study of orotecan (oral irinotecan HCl, VAL-413) in patients with recurrent pediatric solid tumors
    Bacha, Jeffrey
    Brown, Dennis
    Kanekal, Sarath
    Sankar, Neil
    Lopez, Lorena
    Yam, Noymi
    Wagner, Lars
    Geller, James
    Leggas, Markos
    Thompson, Patrick
    Osterheld, Javier
    CANCER RESEARCH, 2023, 83 (08)
  • [44] A pilot clinical study of VAL-413 (oral irinotecan HCl) in patients with recurrent pediatric solid tumors.
    Brown, Dennis
    Bacha, Jeffrey A.
    Geller, James I.
    Thompson, Patrick A.
    Oesterheld, Javier E.
    Kanekal, Sarath
    Leggas, Markos
    Lopez, Lorena
    Sankar, Neil
    Yam, Noymi
    Wagner, Lars M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: A pediatric oncology phase II study
    Hurwitz, CA
    Strauss, LC
    Kepner, J
    Kretschmar, C
    Harris, MB
    Friedman, H
    Kun, L
    Kadota, R
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (05) : 277 - 281
  • [46] Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma
    Dogan, Izzet
    Iribas, Ayca
    Ahmed, Melin Aydan
    Basaran, Mert
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (04) : 343 - 347
  • [47] EXPERIENCE WITH VINCRISTINE IN SOLID TUMORS
    GUBISCH, NJ
    NORENA, D
    PERLIA, CP
    TAYLOR, SG
    CANCER CHEMOTHERAPY REPORTS, 1963, (32): : 19 - 22
  • [48] A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors
    Jonathan Metts
    Brittany Harrington
    Emad Salman
    Scott M. Bradfield
    Jennifer Flanary
    Maua Mosha
    Ernest Amankwah
    Stacie Stapleton
    Child's Nervous System, 2022, 38 : 919 - 928
  • [49] A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors
    Metts, Jonathan
    Harrington, Brittany
    Salman, Emad
    Bradfield, Scott M.
    Flanary, Jennifer
    Mosha, Maua
    Amankwah, Ernest
    Stapleton, Stacie
    CHILDS NERVOUS SYSTEM, 2022, 38 (05) : 919 - 928
  • [50] A Phase 1/Pilot Study of Radiofrequency Ablation for the Treatment of Recurrent Pediatric Solid Tumors
    Hoffer, Fredric A.
    Daw, Najat C.
    Xiong, Xiaoping
    Anghelescu, Doralina
    Krasin, Matthew
    Yan, Xiaowei
    Davidoff, Andrew M.
    Furman, Wayne L.
    Rodriguez-Galindo, Carlos
    Spunt, Sheri L.
    CANCER, 2009, 115 (06) : 1328 - 1337
12345